Glossary

Filter By:
2 A B C D E F G H I K M N O P R S T U X

N

NAC

National Advisory Council

NCATS

National Center for Advancing Translational Sciences

NCCAM

National Center for Complementary and Alternative Medicine (dissolved 12/2014)

NCCIH

National Center for Complementary and Integrative Health

NCI

NIH National Cancer Institute

NCRR

NIH National Center for Research Resources (dissolved 12/2011)

NED

NIH Enterprise Directory

NEI

NIH National Eye Institute

New Investigator

A PD/PI who has not previously competed successfully as a PD/PI for a substantial independent research award is considered a New Investigator.

NIA

NIH National Institute on Aging

NIAAA

NIH National Institute on Alcohol Abuse and Alcoholism

NIAID

NIH National Institute of Allergy and Infectious Diseases

NIAMS

NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases

NIBIB

NIH National Institute of Biomedical Imaging and Bioengineering

NICHD

National Institute of Child Health and Human Development

NIDA

NIH National Institute on Drug Abuse

NIDCD

NIH National Institute on Deafness and Other Communication Disorders

NIDCR

NIH National Institute of Dental and Craniofacial Research

NIDDK

NIH National Institute of Diabetes and Digestive and Kidney Diseases

NIEHS

NIH National Institute of Environmental Health Sciences

NIGMS

NIH National Institute of General Medical Sciences

NIH

National Institutes of Health - A Federal agency whose mission is to improve the health of the people of the United States. NIH is a part of the Public Health Service, which is part of the U.S. Department of Health and Human Services.

NIH Guide for Grants and Contracts

The official publication for NIH's medical and behavioral research grants policies, guidelines and funding opportunities.

NIH-Defined Phase III Clinical Trial

An NIH-defined Phase III clinical trial is a broadly based prospective Phase III clinical investigation, usually involving several hundred or more human subjects, for the purpose of evaluating an experimental intervention in comparison with a standard or controlled intervention or comparing two or more existing treatments. Often the aim of such investigation is to provide evidence leading to a scientific basis for consideration of a change in health policy or standard of care. The definition includes pharmacologic, non-pharmacologic, and behavioral interventions given for disease prevention, prophylaxis, diagnosis, or therapy. Community trials and other population-based intervention trials are also included.

NIH/OD

National Institutes of Health, Office of the Director

NIMH

NIH National Institute of Mental Health

No-Cost Extension

An extension of time to a project period and/or budget period to complete the work of the grant under that period, without additional Federal funds or competition. See NIH Standard Terms of Award and Prior Approval Requirements.

Non-Competing Continuation Application/Award

A financial assistance request (in the form of an application or progress report) or resulting award for a subsequent budget period within a previously approved project period for which a recipient does not have to compete with other applicants.

Non-competing Continuation Awards

A financial assistance request (in the form of an application or progress report) or resulting award for a subsequent budget period within a previously approved project period for which a recipient does not have to compete with other applicants.

Non-Federal Entity

A state, local government, Indian tribe, institution of higher education (IHE), or nonprofit organization that carries out a Federal award as a recipient or subrecipient.

NOSI

Notices posted in the NIH Guide for Grants and Contracts that succinctly highlight a specific topic of interest, for example a specific area of research or program. These notices direct applicants to one or more active funding opportunity announcements (often parent announcements) for submission of applications for the initiative described. Many program announcements will be issued as Notices of Special Interest going forward.

NOSI

Notices posted in the NIH Guide for Grants and Contracts that succinctly highlight a specific topic of interest, for example a specific area of research or program. These notices direct applicants to one or more active funding opportunity announcements (often parent announcements) for submission of applications for the initiative described. Many program announcements will be issued as Notices of Special Interest going forward.

NRFC

An application may be designated Not Recommended for Further Consideration (NRFC) by the Scientific Review Group if it lacks significant and substantial merit; presents serious ethical problems in the protection of human subjects from research risks; or presents serious ethical problems in the use of vertebrate animals, biohazards, and/or select agents. Applications designated as NRFC do not proceed to the second level of peer review (National Advisory Council/Board) because they cannot be funded.

NRSA

National Research Service Award - Ruth L. Kirschstein National Research Service Award (NRSA)